Cargando…

CD4(+) T cell activation and inflammation in NASH-related fibrosis

Liver fibrosis is a common pathological feature of end stage liver failure, a severe life-threatening disease worldwide. Nonalcoholic fatty liver disease (NAFLD), especially its more severe form with steatohepatitis (NASH), results from obesity, type 2 diabetes and metabolic syndrome and becomes a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yunfeng, Zhang, Haibo, Yao, Yao, Zhang, Xiaoyan, Guan, Youfei, Zheng, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399803/ https://www.ncbi.nlm.nih.gov/pubmed/36032141 http://dx.doi.org/10.3389/fimmu.2022.967410

Ejemplares similares

Prostaglandin E(2) Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
por: Zhou, Yu, et al.
Publicado: (2018)

The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
por: Du, Wei, et al.
Publicado: (2022)

CD3(+)CD4(-)CD8(-) (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer
por: Wu, Zhiheng, et al.
Publicado: (2022)

Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and Activation
por: Li, Xi, et al.
Publicado: (2017)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model
por: van Koppen, Arianne, et al.
Publicado: (2017)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis
por: Shen, Xin, et al.
Publicado: (2017)

The difference in CD4(+) T cell immunity between high- and low-virulence Tembusu viruses is mainly related to residues 151 and 304 in the envelope protein
por: Meng, Runze, et al.
Publicado: (2022)

Construction of prediction model of inflammation related genes in idiopathic pulmonary fibrosis and its correlation with immune microenvironment
por: Yin, Ying-Qiu, et al.
Publicado: (2022)

Phenotypic Characterization of CD4(+) T Lymphocytes in Periportal Fibrosis Secondary to Schistosomiasis
por: Santana, Jordana Batista, et al.
Publicado: (2021)

Reactive oxygen species formation and its effect on CD4(+) T cell-mediated inflammation
por: Shu, Panyin, et al.
Publicado: (2023)

The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice
por: Lee, Seul, et al.
Publicado: (2020)

Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis
por: Ma, Tiankui, et al.
Publicado: (2022)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
por: Yu, Simiao, et al.
Publicado: (2022)

PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice
por: Yang, Jichun, et al.
Publicado: (2008)

Multicytokine-producing CD4(+) T cells characterize the livers of patients with NASH
por: Woestemeier, Anna, et al.
Publicado: (2023)

CD4(+) T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice
por: Her, Zhisheng, et al.
Publicado: (2020)

Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
por: Traber, Peter G., et al.
Publicado: (2013)

BET Inhibition Improves NASH and Liver Fibrosis
por: Middleton, Sarah A., et al.
Publicado: (2018)

Editorial: Immune mechanisms of inflammation in NASH
por: Hirsova, Petra, et al.
Publicado: (2022)

BMP4 Moderates Glycolysis and Regulates Activation and Interferon-Gamma Production in CD4+ T Cells
por: Huang, Feng, et al.
Publicado: (2021)

Hypermethylation of Smad7 in CD4(+) T cells is associated with the disease activity of rheumatoid arthritis
por: Hu, Yiping, et al.
Publicado: (2023)

Adjunct Therapy for CD4(+) T-Cell Recovery, Inflammation and Immune Activation in People Living With HIV: A Systematic Review and Meta-Analysis
por: Zhang, Yang, et al.
Publicado: (2021)

FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models
por: O’Farrell, Marie, et al.
Publicado: (2022)

PPARγ as an E3 Ubiquitin-Ligase Impedes Phosphate-Stat6 Stability and Promotes Prostaglandins E(2)-Mediated Inhibition of IgE Production in Asthma
por: Wu, Jia, et al.
Publicado: (2020)

CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro
por: Silva-Cardoso, Sandra C., et al.
Publicado: (2020)

The Prognostic Value of Integrated Analysis of Inflammation and Hypoxia-Related Genes in Idiopathic Pulmonary Fibrosis
por: Liu, Jun, et al.
Publicado: (2022)

sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH
por: Hall, Katherine C., et al.
Publicado: (2019)

Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis
por: Wen, Jun-Hao, et al.
Publicado: (2022)

Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection
por: Zhang, Lumin, et al.
Publicado: (2020)

A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
por: Li, Xuecheng, et al.
Publicado: (2023)

IL-27 Regulated CD4(+)IL-10(+) T Cells in Experimental Sjögren Syndrome
por: Qi, Jingjing, et al.
Publicado: (2020)

A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells
por: Hu, Jianping, et al.
Publicado: (2021)

CD32 Ligation Promotes the Activation of CD4(+) T Cells
por: Holgado, María Pía, et al.
Publicado: (2018)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020)

Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cji348rbti0itrc7sollckasmo